# Morphic Therapeutic (stock symbol: MORF) Logo in transparent PNG and SVG formats

## Morphic Therapeutic Logo large

### Morphic Therapeutic Logo large Download PNG (64.84 KB)

![Morphic Therapeutic Logo large Download PNG (64.84 KB)](/img/orig/MORF_BIG-1d09e18b.png)

### Morphic Therapeutic Logo large Download SVG (60.56 KB)

![Morphic Therapeutic Logo large Download SVG (60.56 KB)](/img/orig/MORF_BIG-d5ca77db.svg)

## Morphic Therapeutic Logo icon format

### Morphic Therapeutic Logo icon format Download PNG (182.05 KB)

![Morphic Therapeutic Logo icon format Download PNG (182.05 KB)](/img/orig/MORF-3c22b155.png)

### Morphic Therapeutic Logo icon format Download SVG (60.3 KB)

![Morphic Therapeutic Logo icon format Download SVG (60.3 KB)](/img/orig/MORF-78603ac5.svg)

## Morphic Therapeutic Logo large for dark backgrounds

### Morphic Therapeutic Logo large for dark backgrounds Download PNG (31.72 KB)

![Morphic Therapeutic Logo large for dark backgrounds Download PNG (31.72 KB)](/img/orig/MORF_BIG.D-f3dadb2a.png)

### Morphic Therapeutic Logo large for dark backgrounds Download SVG (45.75 KB)

![Morphic Therapeutic Logo large for dark backgrounds Download SVG (45.75 KB)](/img/orig/MORF_BIG.D-bb0738a5.svg)

## Morphic Therapeutic Logo icon format for dark backgrounds

### Morphic Therapeutic Logo icon format for dark backgrounds Download PNG (77.15 KB)

![Morphic Therapeutic Logo icon format for dark backgrounds Download PNG (77.15 KB)](/img/orig/MORF.D-f8f75cbf.png)

### Morphic Therapeutic Logo icon format for dark backgrounds Download SVG (45.4 KB)

![Morphic Therapeutic Logo icon format for dark backgrounds Download SVG (45.4 KB)](/img/orig/MORF.D-0e23ea1f.svg)

## About Morphic Therapeutic

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ÃŸ7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avÃŸ6 for the treatment of fibrotic diseases, and avÃŸ8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with SchrÃ¶dinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

1. Website domain: morphictx.com
2. Employees: 101
3. Marketcap: $1.87 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
